Log in

NASDAQ:ASLNASLAN PHARMACEU/ADR News Headlines

$1.73
-0.02 (-1.14 %)
(As of 05/25/2020 04:00 PM ET)
Add
Compare
Today's Range
$1.67
Now: $1.73
$1.77
50-Day Range
$0.97
MA: $1.57
$1.90
52-Week Range
$0.35
Now: $1.73
$8.18
Volume77,400 shs
Average Volume124,828 shs
Market Capitalization$55.45 million
P/E RatioN/A
Dividend YieldN/A
Beta3.34

Headlines

ASLAN PHARMACEU/ADR (NASDAQ ASLN) News Headlines

Source:
DateHeadline
ASLAN PHARMACEU/ADR Expected to Post Q2 2020 Earnings of ($0.10) Per Share (NASDAQ:ASLN)ASLAN PHARMACEU/ADR Expected to Post Q2 2020 Earnings of ($0.10) Per Share (NASDAQ:ASLN)
www.americanbankingnews.com - May 14 at 1:55 PM
ASLAN PHARMACEU/ADR (NASDAQ:ASLN) Expected to Post Earnings of -$0.12 Per ShareASLAN PHARMACEU/ADR (NASDAQ:ASLN) Expected to Post Earnings of -$0.12 Per Share
www.americanbankingnews.com - May 12 at 10:12 PM
ASLAN PHARMACEU/ADR (NASDAQ:ASLN) Stock Rating Reaffirmed by HC WainwrightASLAN PHARMACEU/ADR (NASDAQ:ASLN) Stock Rating Reaffirmed by HC Wainwright
www.americanbankingnews.com - May 12 at 12:12 PM
ASLAN Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Corporate UpdateASLAN Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Corporate Update
finance.yahoo.com - May 11 at 8:26 AM
ASLAN Pharmaceuticals Ltd (ASLN) Gains But Lags Market: What You Should KnowASLAN Pharmaceuticals Ltd (ASLN) Gains But Lags Market: What You Should Know
finance.yahoo.com - May 7 at 7:04 PM
Gilead (GILD) in Focus: Stock Moves 9.7% HigherGilead (GILD) in Focus: Stock Moves 9.7% Higher
finance.yahoo.com - April 20 at 9:51 AM
ASLAN Intends to Resume Screening as Soon as Government Restrictions are Lifted and is Taking Steps to Open Sites in Australia to Accelerate RecruitmentASLAN Intends to Resume Screening as Soon as Government Restrictions are Lifted and is Taking Steps to Open Sites in Australia to Accelerate Recruitment
finance.yahoo.com - April 13 at 8:04 AM
ASLAN Pharmaceuticals Ltd. (ASLN) Upgraded to Buy: What Does It Mean for the Stock?ASLAN Pharmaceuticals Ltd. (ASLN) Upgraded to Buy: What Does It Mean for the Stock?
finance.yahoo.com - March 26 at 5:12 PM
ASLAN Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate UpdateASLAN Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
finance.yahoo.com - March 18 at 8:50 AM
ASLAN Pharmaceuticals Ltd. (ASLN) Dips More Than Broader Markets: What You Should KnowASLAN Pharmaceuticals Ltd. (ASLN) Dips More Than Broader Markets: What You Should Know
finance.yahoo.com - February 20 at 7:27 PM
ASLAN Pharmaceuticals Ltd. (ASLN) Stock Sinks As Market Gains: What You Should KnowASLAN Pharmaceuticals Ltd. (ASLN) Stock Sinks As Market Gains: What You Should Know
finance.yahoo.com - February 10 at 7:36 PM
ASLAN Pharmaceuticals Ltd. (ASLN) Gains But Lags Market: What You Should KnowASLAN Pharmaceuticals Ltd. (ASLN) Gains But Lags Market: What You Should Know
finance.yahoo.com - February 4 at 7:16 PM
Has ASLAN Pharmaceuticals (ASLN) Outpaced Other Medical Stocks This Year?Has ASLAN Pharmaceuticals (ASLN) Outpaced Other Medical Stocks This Year?
finance.yahoo.com - January 27 at 12:19 PM
Momenta (MNTA) Provides Pipeline Updates, Stock RalliesMomenta (MNTA) Provides Pipeline Updates, Stock Rallies
finance.yahoo.com - January 15 at 9:15 AM
Is ASLAN Pharmaceuticals (ASLN) Outperforming Other Medical Stocks This Year?Is ASLAN Pharmaceuticals (ASLN) Outperforming Other Medical Stocks This Year?
finance.yahoo.com - January 6 at 5:06 PM
Aslan shares rise 6% on heavy volumeAslan shares rise 6% on heavy volume
finance.yahoo.com - December 18 at 2:20 PM
26 Stocks Moving in Wednesdays Pre-Market Session26 Stocks Moving in Wednesday's Pre-Market Session
www.msn.com - December 5 at 10:48 PM
ASLAN Pharmaceuticals Announces Closing of US$15 Million Public Offering of American Depositary Shares, Including Full Exercise of Underwriter’s Option to Purchase Additional ADSsASLAN Pharmaceuticals Announces Closing of US$15 Million Public Offering of American Depositary Shares, Including Full Exercise of Underwriter’s Option to Purchase Additional ADSs
finance.yahoo.com - December 5 at 10:48 PM
Aslan Pharmaceuticals stock plunges after stock offering prices at a 52% discountAslan Pharmaceuticals stock plunges after stock offering prices at a 52% discount
finance.yahoo.com - December 3 at 6:07 PM
ASLAN Pharmaceuticals Announces Pricing of $12.8 Million Public Offering of American Depositary SharesASLAN Pharmaceuticals Announces Pricing of $12.8 Million Public Offering of American Depositary Shares
finance.yahoo.com - December 3 at 7:54 AM
Aslans Rally Grows After Positive Readout From Eczema Drug StudyAslan's Rally Grows After Positive Readout From Eczema Drug Study
www.msn.com - December 2 at 7:13 PM
Aslan Pharmaceuticals Announces Proposed Public Offering of American Depositary SharesAslan Pharmaceuticals Announces Proposed Public Offering of American Depositary Shares
finance.yahoo.com - December 2 at 2:13 PM
Aslan stock pares its big gain after announcing stock offeringAslan stock pares its big gain after announcing stock offering
finance.yahoo.com - December 2 at 2:13 PM
ASLAN Pharmaceuticals Reports Positive Preliminary Data From Proof-of-Concept Study for ASLAN004 Targeting Atopic DermatitisASLAN Pharmaceuticals Reports Positive Preliminary Data From Proof-of-Concept Study for ASLAN004 Targeting Atopic Dermatitis
finance.yahoo.com - December 2 at 9:12 AM
Aslan Pharmaceuticals' stock soars on heavy volume, after rocketing nearly 9-fold the past weekAslan Pharmaceuticals' stock soars on heavy volume, after rocketing nearly 9-fold the past week
finance.yahoo.com - December 2 at 9:12 AM
ASLAN Pharmaceuticals Announces Publication of Preclinical Data on ASLAN003 in AML in Haematologica JournalASLAN Pharmaceuticals Announces Publication of Preclinical Data on ASLAN003 in AML in Haematologica Journal
finance.yahoo.com - November 22 at 8:07 AM
Aslan Dips Into Penny Stock Territory After Company Flunks Late-Stage Cancer StudyAslan Dips Into Penny Stock Territory After Company Flunks Late-Stage Cancer Study
www.benzinga.com - November 11 at 1:25 PM
Will ASLAN Continue to Surge Higher?Will ASLAN Continue to Surge Higher?
finance.yahoo.com - November 11 at 8:24 AM
ASLAN Pharmaceuticals Ltd. (ASLN) Moves to Strong Buy: Rationale Behind the UpgradeASLAN Pharmaceuticals Ltd. (ASLN) Moves to Strong Buy: Rationale Behind the Upgrade
finance.yahoo.com - November 8 at 11:45 AM
ASLAN Pharmaceuticals Enrolls First Patient in Proof-of-Concept Study for ASLAN004 Targeting Atopic DermatitisASLAN Pharmaceuticals Enrolls First Patient in Proof-of-Concept Study for ASLAN004 Targeting Atopic Dermatitis
finance.yahoo.com - October 22 at 8:30 AM
New Data Presented on ASLAN’s varlitinib at ESMO 2019New Data Presented on ASLAN’s varlitinib at ESMO 2019
finance.yahoo.com - October 2 at 6:45 AM
ASLAN Pharmaceuticals and Bukwang Pharmaceutical Establish a Joint Venture, JAGUAHR Therapeutics, to Develop Novel Immuno-Oncology TherapiesASLAN Pharmaceuticals and Bukwang Pharmaceutical Establish a Joint Venture, JAGUAHR Therapeutics, to Develop Novel Immuno-Oncology Therapies
finance.yahoo.com - September 30 at 6:47 AM
ASLAN Pharmaceuticals Presents Late-Breaking Data From Phase 2 Study in China Testing Varlitinib in Second Line Biliary Tract Cancer at CSCOASLAN Pharmaceuticals Presents Late-Breaking Data From Phase 2 Study in China Testing Varlitinib in Second Line Biliary Tract Cancer at CSCO
finance.yahoo.com - September 19 at 9:40 AM
Abstract on ASLAN Pharmaceuticals’ Varlitinib Accepted for Poster Presentation at ESMO Asia Congress 2019Abstract on ASLAN Pharmaceuticals’ Varlitinib Accepted for Poster Presentation at ESMO Asia Congress 2019
finance.yahoo.com - September 10 at 11:32 AM
New Data From Aslan’s Study of Varlitinib in China Accepted as Late-Breaking Oral Presentation at 2019 CSCO Annual MeetingNew Data From Aslan’s Study of Varlitinib in China Accepted as Late-Breaking Oral Presentation at 2019 CSCO Annual Meeting
finance.yahoo.com - August 27 at 12:09 PM
ASLAN Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Corporate UpdateASLAN Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Corporate Update
finance.yahoo.com - August 13 at 10:56 AM
ASLAN Pharmaceuticals to Present New Data on Varlitinib at European Society for Medical Oncology CongressASLAN Pharmaceuticals to Present New Data on Varlitinib at European Society for Medical Oncology Congress
finance.yahoo.com - July 31 at 1:08 PM
ASLAN Pharmaceuticals Names Industry Veteran and Current Board Member Andrew Howden to Additional Role of ChairmanASLAN Pharmaceuticals Names Industry Veteran and Current Board Member Andrew Howden to Additional Role of Chairman
finance.yahoo.com - July 26 at 9:08 AM
ASLAN Pharmaceuticals Ltd. (ASLN) Upgraded to Strong Buy: Here's WhyASLAN Pharmaceuticals Ltd. (ASLN) Upgraded to Strong Buy: Here's Why
finance.yahoo.com - July 1 at 11:21 AM
ASLAN Pharmaceuticals Completes Phase 1 Study for ASLAN004 Targeting Atopic DermatitisASLAN Pharmaceuticals Completes Phase 1 Study for ASLAN004 Targeting Atopic Dermatitis
finance.yahoo.com - June 4 at 11:53 AM
ASLAN Pharmaceuticals Ltd. (ASLN) Upgraded to Buy: Here's WhyASLAN Pharmaceuticals Ltd. (ASLN) Upgraded to Buy: Here's Why
finance.yahoo.com - May 6 at 11:40 AM
ASLAN Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Corporate UpdateASLAN Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Corporate Update
finance.yahoo.com - April 29 at 11:30 AM
Asian ADRs in Tuesday TradingAsian ADRs in Tuesday Trading
www.nasdaq.com - April 2 at 11:33 AM
ASLAN Pharmaceuticals Completes First Part of Single Ascending Dose Study for ASLAN004 Targeting Atopic DermatitisASLAN Pharmaceuticals Completes First Part of Single Ascending Dose Study for ASLAN004 Targeting Atopic Dermatitis
finance.yahoo.com - March 29 at 12:29 PM
ASLAN Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate UpdateASLAN Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update
finance.yahoo.com - March 22 at 12:09 PM
ASLAN Pharmaceuticals Signs New Agreement With Biogenetics for Commercialisation of ASLAN003 in South KoreaASLAN Pharmaceuticals Signs New Agreement With Biogenetics for Commercialisation of ASLAN003 in South Korea
finance.yahoo.com - March 11 at 8:55 AM
ASLAN Pharmaceuticals to Partner With BioGenetics on Commercialisation of Varlitinib in South KoreaASLAN Pharmaceuticals to Partner With BioGenetics on Commercialisation of Varlitinib in South Korea
finance.yahoo.com - February 27 at 12:13 PM
ASLAN Pharmaceuticals Announces Strategic Prioritisation of Clinical Development Programs and Corporate RestructuringASLAN Pharmaceuticals Announces Strategic Prioritisation of Clinical Development Programs and Corporate Restructuring
finance.yahoo.com - January 30 at 11:31 AM
The Daily Biotech Pulse: PTC Therapeutics, Select Biosciences Offering, Unity Biotech Expands Early-Stage Osteoarthritis Drug StudyThe Daily Biotech Pulse: PTC Therapeutics, Select Biosciences Offering, Unity Biotech Expands Early-Stage Osteoarthritis Drug Study
finance.yahoo.com - January 25 at 3:44 PM
Aslan Pharmaceuticals Ltd. ADRAslan Pharmaceuticals Ltd. ADR
www.barrons.com - January 24 at 3:44 PM
This page was last updated on 5/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.